We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
Cap. Flow
+$552M
Cap. Flow %
5.91%
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$39.4M
3
INTC icon
Intel
INTC
+$29.2M
4
QCOM icon
Qualcomm
QCOM
+$27.6M
5
DHR icon
Danaher
DHR
+$26M

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 19.55%
3 Financials 10.18%
4 Consumer Discretionary 9.32%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLAB icon
526
Mesa Laboratories
MLAB
$540M
$2.04M 0.02%
8,200
-4,073
-33% -$954K
L icon
527
Loews
L
$24.4B
$2.04M 0.02%
38,884
-7,912
-17% -$399K
PXD
528
DELISTED
Pioneer Natural Resource Co.
PXD
$2.04M 0.02%
13,468
+494
+4% +$65.8K
NUE icon
529
Nucor
NUE
$56.4B
$2.03M 0.02%
36,062
-2,830
-7% -$154K
CTAS icon
530
Cintas
CTAS
$84.4B
$2.03M 0.02%
30,112
+2,812
+10% +$185K
ABEV icon
531
Ambev
ABEV
$47.4B
$2M 0.02%
429,370
+273,649
+176% +$1.21M
SPR
532
DELISTED
Spirit AeroSystems
SPR
$1.98M 0.02%
27,128
+1,212
+5% +$100K
CAH icon
533
Cardinal Health
CAH
$53.7B
$1.94M 0.02%
38,352
+4,787
+14% +$247K
O icon
534
Realty Income
O
$61.1B
$1.93M 0.02%
27,113
-3,160
-10% -$235K
MYOV
535
DELISTED
Myovant Sciences Ltd.
MYOV
$1.92M 0.02%
+123,632
New +$1.25M
WAT icon
536
Waters Corp
WAT
$36.4B
$1.9M 0.02%
8,141
+178
+2% +$39.3K
WEX icon
537
WEX
WEX
$6.17B
$1.89M 0.02%
9,029
+396
+5% +$79.4K
TYL icon
538
Tyler Technologies
TYL
$13B
$1.88M 0.02%
6,253
-641
-9% -$179K
ANAB icon
539
AnaptysBio
ANAB
$1.59B
$1.87M 0.02%
115,000
+65,000
+130% +$1.54M
IDXX icon
540
Idexx Laboratories
IDXX
$43.9B
$1.87M 0.02%
7,153
+1,358
+23% +$358K
BKI
541
DELISTED
Black Knight, Inc. Common Stock
BKI
$1.86M 0.02%
+28,887
New +$1.79M
SNA icon
542
Snap-on
SNA
$21.1B
$1.83M 0.02%
10,791
-1,672
-13% -$273K
WTRG icon
543
Essential Utilities
WTRG
$11.2B
$1.82M 0.02%
+38,759
New +$1.75M
LVS icon
544
Las Vegas Sands
LVS
$31.6B
$1.81M 0.02%
26,247
-23,567
-47% -$1.47M
AAP icon
545
Advance Auto Parts
AAP
$3.48B
-5,314
Closed -$851K
SU icon
546
Suncor Energy
SU
$75.6B
$1.8M 0.02%
54,805
-14,428
-21% -$450K
VMC icon
547
Vulcan Materials
VMC
$36.9B
$1.8M 0.02%
12,487
+1,665
+15% +$238K
YMAB
548
DELISTED
Y-mAbs Therapeutics
YMAB
$1.8M 0.02%
+57,526
New +$1.7M
WDC icon
549
Western Digital
WDC
$172B
$1.79M 0.02%
37,379
-1,911
-5% -$79.7K
ALGN icon
550
Align Technology
ALGN
$12B
$1.79M 0.02%
6,391
-1,252
-16% -$312K

Similar funds

Candriam SCA's Q4 2019 Portfolio in Review

As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.

  • Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
  • Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
  • Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
  • Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
  • Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
  • Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.

Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.